Anal cancer | |
---|---|
Diagram showing stage 1 anal cancer | |
Specialty | Oncology |
Symptoms | Anal bleeding or lump[1] |
Usual onset | Age over 45 years[2] |
Types | Squamous cell carcinoma, adenocarcinoma, small cell carcinoma, melanoma[3] |
Risk factors | Human papillomavirus (HPV), HIV/AIDS, receptive anal sex, smoking, many sexual partners[1][4] |
Diagnostic method | Physical examination, tissue biopsy[1] |
Differential diagnosis | Anal warts, hemorrhoids, anal fissure[5] |
Prevention | HPV vaccination, avoiding risk factors[6] |
Treatment | Radiation therapy, chemotherapy, surgery[1] |
Prognosis | Five year survival ~68% (US 2015)[2] |
Frequency | 8,300 (US 2019)[2] |
Deaths | 1,280 (US 2019)[2] |
Anal cancer is a cancer which arises from the anus, the distal opening of the gastrointestinal tract.[1] Symptoms may include bleeding from the anus or a lump near the anus.[1] Other symptoms may include pain, itchiness, or discharge from the anus.[1] A change in bowel movements may also occur.[1]
Risk factors include human papillomavirus (HPV), HIV/AIDS, receptive anal sex,[4] smoking, and many sexual partners.[1] Anal cancer is typically a squamous cell carcinoma.[3] Other types include adenocarcinoma, small cell carcinoma, and melanoma.[3] Diagnosis is suspected based on physical examination and confirmed by tissue biopsy.[1]
Prevention includes avoiding risk factors and HPV vaccination.[6] Standard treatment may include radiation therapy, chemotherapy, and surgery.[1] About 8,300 people are diagnosed a year in the United States, representing about 0.5% of new cancers.[2] Onset is typically after the age of 45.[2] Women are affected more often than men.[2] The number of cases has increased since the 1990s.[3] The five-year survival rate in the United States is 68%.[2]
{{cite journal}}
: CS1 maint: numeric names: authors list (link)